# Long Term Outcome of Intravitreal Ranibizumab for ROP

> **NCT04537065** · — · COMPLETED · sponsor: **Ameera Gamal Abdelhameed** · enrollment: 140 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **OTHER:** cycloplegic refraction

## Key facts

- **NCT ID:** NCT04537065
- **Lead sponsor:** Ameera Gamal Abdelhameed
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2018-09-01
- **Final completion:** 2018-09-01
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2020-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04537065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04537065, "Long Term Outcome of Intravitreal Ranibizumab for ROP". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04537065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*